REYNALY CAMPOS: Open Payments
NPI 1154922300 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,361 in 88 payments from 25 companies in 2025. Trend: 2023 $297 · 2024 $1,099 · 2025 $3,361
Food & beverage: $3,361
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $750 |
| Dexcom, Inc. | 9 | $395 |
| ABBVIE INC. | 11 | $326 |
| Lilly USA, LLC | 7 | $312 |
| Novo Nordisk Inc | 7 | $235 |
| Edwards Lifesciences Corporation | 2 | $203 |
| Amgen Inc. | 6 | $196 |
| PFIZER INC. | 8 | $173 |
| UCB, Inc. | 1 | $125 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $122 |
Products named: AIRSUPRA, BREZTRI, Dexcom G6 Transmitter, QULIPTA, SAPIEN 3 Ultra RESILIA, Ozempic, JARDIANCE, DEXCOM G7 GSS (161).
Industry payments across NV — which companies pay providers there.
